Cardiac drug overdose.
Toxicity from cardiac drugs is a particular management challenge since the manifestations of an acute overdose and the initial indications for the drug are often similar. Plasma drug levels are essential but must be interpreted in light of the clinical picture. Hypotension, due to either vasodilatation or decreased myocardial contractility, and arrhythmias are the principal cardiac manifestations, but noncardiac effects are sometimes more troublesome. An antiarrhythmic agent of the same class should not be used in treating an arrhythmia resulting from an overdose.
D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D001949:Bretylium Compounds / Q000378:metabolism / Q000506:poisoning; D002317:Cardiovascular Agents / Q000378:metabolism / Q000506:poisoning*; D002318:Cardiovascular Diseases / Q000188:drug therapy; D004077:Digoxin / Q000037:antagonists & inhibitors / Q000506:poisoning; D004206:Disopyramide / Q000378:metabolism / Q000506:poisoning; D006801:Humans; D007022:Hypotension / Q000139:chemically induced; D008012:Lidocaine / Q000378:metabolism / Q000506:poisoning; D008099:Liver / Q000378:metabolism; D010672:Phenytoin / Q000008:administration & dosage / Q000378:metabolism; D011342:Procainamide / Q000378:metabolism / Q000506:poisoning; D011433:Propranolol / Q000378:metabolism / Q000506:poisoning; D011802:Quinidine / Q000378:metabolism / Q000506:poisoning; D014665:Vasodilator Agents / Q000378:metabolism / Q000506:poisoning
D001949:Bretylium Compounds; D002317:Cardiovascular Agents; D014665:Vasodilator Agents; D010672:Phenytoin; D004077:Digoxin; D008012:Lidocaine; D011433:Propranolol; D004206:Disopyramide; D011802:Quinidine; D011342:Procainamide